Thursday, June 25, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 920 of 1,261
  1. US 8193151

    Methods for treating atrial or ventricular arrhythmias

    Northwestern University · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  2. US 8193204

    Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  3. US 8193197

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  4. US 8193225

    Isoxazole amides, derivatives and methods of chemical induction of neurogenesis

    The Board of Regents of the University of Texas System · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  5. US 8193211

    Controlled release compositions of gamma-hydroxybutyrate

    Supernus Pharmaceuticals, Inc. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  6. US 8193312

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  7. US 8193330

    Polynucleotides comprising Neurogenin3 promoter and bHLH encoding domains

    The Regents of the University of California · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  8. US 8193339

    Synthesis of β-nucleosides

    PHARMAESSENTIA CORPORATION · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  9. US 8193357

    Androgen receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  10. US 8188283

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  11. US 8188281

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  12. US 8188294

    Process for preparing biphenyl imidazole compounds

    Theravance, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  13. US 8188289

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 29, 2012 · Expires May 24, 2032

    granted
  14. US 8188134

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  15. US 8188275

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 29, 2012 · Expires May 24, 2032

    granted
  16. US 8188076

    Compositions, synthesis, and methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  17. US 8187606

    HPV antigen fusion protein vaccine compositions and uses thereof

    Beijing Sunbio Biotech Co. Ltd. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  18. US 8187605

    Means for the inhibition of anti-β1-adrenergic receptor antibodies

    Julius-Maximilians-Universitat Wurzburg · Granted May 29, 2012 · Expires May 24, 2032

    granted
  19. US 8187872

    Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein

    IMMUNE DESIGN CORP. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  20. US 8188259

    Oligonucleotide-containing pharmacological compositions and their use

    Lakewood Amedex, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  21. US 8188071

    Amino substituted pyridines as potent kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  22. US 8188067

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  23. US 8188276

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  24. US 8188221

    Peptide homing to brain tumors

    The Regents of the University of California, UCSF · Granted May 29, 2012 · Expires May 24, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.